Different mechanisms are involved in the prothrombotic state of COVID-19 patients, including a dysregulated renin–angiotensin–aldosterone system (RAAS), endothelial dysfunction, elevated von Willebrand factor (vWF), and a dysregulated immune response. This evidence concerns the gene REN and COVID-19.